Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Payers

Oliver Wyman's research findings on diversity in healthcare leadership (some of which surprised us).

Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman
Engagement Manager, Oliver Wyman
Principal, Oliver Wyman
Consultant

An analysis of annual premiums by federal poverty level.

Practice Leader, Oliver Wyman Actuarial Consulting

A closer look at how fast change may happen, who could win (and lose), and how the next decade may unfold for incumbents and new market entrants.

Partner, Health & Life Sciences, Oliver Wyman
Senior Knowledge Expert, Health & Life Sciences, Oliver Wyman

27 partnered products were launched last year, with 70 percent joint ventured or co-branded insurance products.

Partner, Health & Life Sciences, Oliver Wyman
Engagement Manager, Oliver Wyman
Associate, Health & Life Sciences, Oliver Wyman

A closer look at why only 30 percent of C-suite teams and 13 percent of CEOs are women.

Insights in your inbox

Subscribe

Hospital systems will be in a precarious position if they all aim for the same North Star. What might their evolution look like in coming years?

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Natural language processing is the perfect example of how AI can maximize people's talents, impact, and value. But its potential is just being realized.

Vice President of Technology, Optum

A detailed look at the 22 new payer-provider partnerships created in Q1 this year.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Engagement Manager, Oliver Wyman
Associate, Health & Life Sciences, Oliver Wyman

Why a focus on the provider is needed to achieve 4 or 5 Stars.

Principal, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

In light of breaking news, the pharma value chain is definitely ripe for disruption. Here's how health plans, employers, and drug companies can adjust to the new normal.

Partner, Health & Life Sciences, Oliver Wyman
Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman
Engagement Manager, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe